Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [31] Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial - a primary care, type 2 diabetes study
    Blonde, L.
    Dagogo-Jack, S.
    Banerji, M. A.
    Pratley, R. E.
    Marcellari, A.
    Braceras, R.
    Purkayastha, D.
    Baron, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (10) : 978 - 986
  • [32] Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial
    Shestakova, Marina
    Kvasnikov, Boris
    Erina, Ekaterina
    Isachenko, Elena
    Andreev, Alexander
    Study Investigators
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (03)
  • [33] Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks
    Kim, Sin Gon
    Kim, Kyoung Jin
    Yoon, Kun Ho
    Chun, Sung Wan
    Park, Kyong Soo
    Choi, Kyung Mook
    Lim, Soo
    Mok, Ji-Oh
    Lee, Hyoung Woo
    Seo, Ji A.
    Cha, Bong-Soo
    Kim, Mi Kyung
    Shon, Ho Sang
    Choi, Dong Seop
    Kim, Doo Man
    DIABETES OBESITY & METABOLISM, 2020, 22 (10) : 1869 - 1873
  • [34] Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
    Susilawati, Elis
    Levita, Jutti
    Susilawati, Yasmiwar
    Sumiwi, Sri Adi
    MEDICAL SCIENCES, 2023, 11 (03)
  • [35] Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes
    He, Yan-Ling
    Sabo, Ron
    Picard, Franck
    Wang, Yibin
    Herron, Jerry
    Ligueros-Saylan, Monica
    Dole, William P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1265 - 1272
  • [36] Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
    Hollander, Priscilla
    Li, Jia
    Allen, Elsie
    Chen, Roland
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) : 4810 - 4819
  • [37] Thiazolidinediones: clinical use in type 2 diabetes treatment
    Cioni, F.
    Ramelli, L.
    PROGRESS IN NUTRITION, 2009, 11 (01): : 69 - 73
  • [38] Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice Study
    Salmen, Teodor
    Rizvi, Ali Abbas
    Rizzo, Manfredi
    Pietrosel, Valeria-Anca
    Bica, Ioana-Cristina
    Diaconu, Cosmina Theodora
    Potcovaru, Claudia Gabriela
    Salmen, Bianca-Margareta
    Coman, Oana Andreia
    Bobirca, Anca
    Stoica, Roxana-Adriana
    Stoian, Anca
    BIOMEDICINES, 2023, 11 (09)
  • [39] Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents
    Dandona, P
    Aljada, A
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (02) : 91 - 102
  • [40] Efficacy and Safety of Colesevelam in Combination with Pioglitazone in Patients with Type 2 Diabetes Mellitus
    Rosenstock, J.
    Truitt, K. E.
    Baz-Hecht, M.
    Ford, D. M.
    Tao, B.
    Chou, H. S.
    HORMONE AND METABOLIC RESEARCH, 2014, 46 (13) : 943 - 949
12345